Tag: action

The Recognition Honors The Company’s Work Embedding Conversational AI Analytics Into Enterprises’ Existing Ecosystems

Updated features help consumers manage collection activity, reduce unwanted collector contact, identify potential rights issues, and explore legal support options through independent attorneys.

STOCKHOLM, Sweden, June 25, 2026 – AnaCardio, a clinical stage biopharmaceutical company developing novel drugs to treat heart failure, today announced the publication in The Lancet of results from its Phase 1b/2a GOAL-HF1 study evaluating AC01, a first-in-class, oral calcium-sensitising contractile agent, in patients with heart failure with reduced ejection fraction (HFrEF). The results showed a favourable safety and tolerability profile, dose-proportional pharmacokinetics with confirmed target engagement. In exploratory efficacy analyses, numerical rapid and sustained improvements in haemodynamics and cardiac structure and function were observed on top of optimised guideline-directed medical therapy (GDMT).

Sanofi Foundation opens new chapter centered on future generations

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Futu Holdings Limited (NASDAQ: FUTU) resulting from allegations that Futu may have issued materially misleading business information to the investing public.

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Graphic Packaging Holding Company (NYSE: GPK) between February 4, 2025 and February 2, 2026, inclusive (the “Class Period”), of the important July 6, 2026 lead plaintiff deadline.

LONDON, Ontario, 25 juin 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc.. (« Aduro » ou la « Société ») (Nasdaq : ADUR) (TSX : ACT) (FSE : 9D5), une société spécialisée dans les technologies propres qui recycle chimiquement les matières premières de plus faible valeur comme les déchets plastiques, le bitume lourd ou les huiles renouvelables pour les transformer en ressources adaptées au XXI^e siècle, a annoncé aujourd’hui, suite à ses communiqués de presse des 10 juin 2026 et 15 juin 2026, la clôture d’un placement privé sans intermédiaire pour un produit brut de 9 155 940,80 dollars canadiens (6 564 810,21 dollars américains) provenant de la vente de 431 884 actions ordinaires (les « actions LIFE ») au prix de 21,20 dollars canadiens (15,20 dollars américains) par action LIFE (l’« Offre LIFE ») en vertu de la Dispense LIFE (telle que définie aux présentes).

— Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control —

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased PicS N.V. (“PicS” or the “Company”) (NASDAQ:PICS) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.